President Moon, SK Bioscience Phase 3 Clinical Trial Raises Expectations for 'Domestic Vaccine'

"Expecting the Birth and Commercialization of the First Domestic Vaccine"... Government Pledges Comprehensive Support

[Image source=Yonhap News]

[Asia Economy Reporter Ryu Jeong-min] Park Kyung-mi, spokesperson for the Blue House, stated on the 10th that President Moon Jae-in expressed expectations for the birth of the 'first domestically produced vaccine' in relation to the Ministry of Food and Drug Safety's approval of SK Bioscience's phase 3 clinical trial plan for the COVID-19 vaccine.

President Moon said, "I hope the first domestically produced vaccine will be born and commercialized," adding, "The government will provide comprehensive support so that domestic clinical trials can be conducted quickly and sufficiently."

Earlier, the Ministry of Food and Drug Safety announced on the 10th that it had approved the phase 3 clinical trial plan for 'GBP510,' a COVID-19 vaccine candidate developed by SK Bioscience. SK Bioscience aims for commercialization in the first half of next year. If successful, hundreds of millions of doses of the domestically produced vaccine are expected to be supplied worldwide.

This content was produced with the assistance of AI translation services.